M. Martínez-Villacampa

Prediction of pathological response to neoadjuvant treatment in rectal cancer with a two-protein immunohistochemical score derived from stromal gene-profiling

Samuel Gonçalves-Ribeiro, Rebeca Sanz‐Pamplona, A. Vidal et al. · Annals of Oncology · 2017 · 43 citations · Full text

Medicine, Oncology, Pathology +17

Randomized study of weekly irinotecan plus high-dose 5-fluorouracil (FUIRI) versus biweekly irinotecan plus 5-fluorouracil/leucovorin (FOLFIRI) as first-line chemotherapy for patients with metastatic colorectal cancer: a Spanish Cooperative Group for the Treatment of Digestive Tumors Study

Enrique Aranda, M. Valladares, M. Martínez-Villacampa et al. · Annals of Oncology · 2008 · 27 citations

Medicine, Oncology, Pharmacology +12

Rechallenge with oxaliplatin and peripheral neuropathy in colorectal cancer patients

Sarah Besora, Cristina Santos, Cristina Izquierdo et al. · Journal of Cancer Research and Clinical Oncology · 2018 · 25 citations · Full text

Pharmacy, Oncology, Cancer Drug Toxicity Management +11

The oncology acute toxicity unit (OATU): an outpatient facility for improving the management of chemotherapy toxicity

Margarita Majem, Maica Galán, S Chicote et al. · Clinical & Translational Oncology · 2007 · 24 citations

Pharmacy, Oncology, Cancer Drug Toxicity Management +15

[Resection as elective treatment of hilar cholangiocarcinoma (Klatskin tumor)].

Juan Figueras, L Lladó-Garriga, Carmen Lama et al. · PubMed · 1998 · 21 citations

Medicine, Oncology, Surgery +8